SVB Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Sell |
93,921
-398
| -0.4% | -$10.4K | 0.14% | 133 |
|
|
2026
Q1 | $2.65M | Sell |
94,319
-23,728
| -20% | -$632K | 0.17% | 114 |
|
|
2025
Q4 | $2.94M | Sell |
118,047
-25,191
| -18% | -$635K | 0.17% | 112 |
|
|
2025
Q3 | $3.65M | Sell |
143,238
-24,844
| -15% | -$613K | 0.2% | 105 |
|
|
2025
Q2 | $4.07M | Buy |
+168,082
| New | +$3.92M | 0.22% | 95 |
|
|
2025
Q1 | – | Sell |
-522,919
| Closed | -$13.9M | – | 1711 |
|
|
2024
Q4 | $13.9M | Buy |
+522,919
| New | +$14.2M | 0.26% | 59 |
|
|
2024
Q3 | – | Sell |
-569,574
| Closed | -$15.9M | – | 435 |
|
|
2024
Q2 | $15.9M | Sell |
569,574
-25,525
| -4% | -$703K | 0.39% | 55 |
|
|
2024
Q1 | $16.5M | Buy |
595,099
+12,539
| +2% | +$348K | 0.37% | 68 |
|
|
2023
Q4 | $16.8M | Sell |
582,560
-35,727
| -6% | -$1.08M | 0.41% | 62 |
|
|
2023
Q3 | $20.5M | Sell |
618,287
-24,628
| -4% | -$871K | 0.45% | 48 |
|
|
2023
Q2 | $23.6M | Buy |
642,915
+211,450
| +49% | +$8.23M | 0.43% | 45 |
|
|
2023
Q1 | $17.6M | Sell |
431,465
-37,165
| -8% | -$1.61M | 0.25% | 86 |
|
|
2022
Q4 | $24M | Sell |
468,630
-1,287
| -0.3% | -$61.7K | 0.32% | 63 |
|
|
2022
Q3 | $20.6M | Buy |
469,917
+22,935
| +5% | +$1.11M | 0.3% | 65 |
|
|
2022
Q2 | $23.4M | Buy |
446,982
+2,312
| +0.5% | +$118K | 0.36% | 58 |
|
|
2022
Q1 | $23M | Buy |
444,670
+7,768
| +2% | +$403K | 0.31% | 62 |
|
|
2021
Q4 | $25.8M | Sell |
436,902
-4,075
| -0.9% | -$202K | 0.42% | 56 |
|
|
2021
Q3 | $19M | Sell |
440,977
-5,909
| -1% | -$262K | 0.24% | 77 |
|
|
2021
Q2 | $17.5M | Sell |
446,886
-7,392
| -2% | -$287K | 0.22% | 87 |
|
|
2021
Q1 | $16.5M | Sell |
454,278
-16,391
| -3% | -$582K | 0.23% | 81 |
|
|
2020
Q4 | $17.3M | Sell |
470,669
-27,966
| -6% | -$1.03M | 0.25% | 75 |
|
|
2020
Q3 | $17.4M | Sell |
498,635
-3,213
| -0.6% | -$113K | 0.29% | 63 |
|
|
2020
Q2 | $15.6M | Buy |
501,848
+818
| +0.2% | +$27.8K | 0.29% | 61 |
|
|
2020
Q1 | $15.5M | Sell |
501,030
-61,593
| -11% | -$2.1M | 0.38% | 47 |
|
|
2019
Q4 | $20.9M | Sell |
562,623
-8,741
| -2% | -$311K | 0.38% | 53 |
|
|
2019
Q3 | $19.5M | Sell |
571,364
-113,275
| -17% | -$4.12M | 0.39% | 52 |
|
|
2019
Q2 | $28.1M | Sell |
684,639
-240,598
| -26% | -$9.55M | 0.95% | 24 |
|
|
2019
Q1 | $37.3M | Sell |
925,237
-29,651
| -3% | -$1.19M | 1.47% | 14 |
|
|
2018
Q4 | $39.5M | Sell |
954,888
-7,363
| -0.8% | -$306K | 1.69% | 11 |
|
|
2018
Q3 | $40.2M | Sell |
962,251
-3,742
| -0.4% | -$144K | 1.42% | 11 |
|
|
2018
Q2 | $33.3M | Sell |
965,993
-35,814
| -4% | -$1.22M | 1.28% | 14 |
|
|
2018
Q1 | $33.7M | Sell |
1,001,807
-16,721
| -2% | -$575K | 1.29% | 12 |
|
|
2017
Q4 | $35M | Sell |
1,018,528
-14,334
| -1% | -$489K | 1.32% | 12 |
|
|
2017
Q3 | $35M | Buy |
1,032,862
+7,487
| +0.7% | +$241K | 1.35% | 11 |
|
|
2017
Q2 | $32.7M | Buy |
1,025,375
+4,886
| +0.5% | +$154K | 1.28% | 14 |
|
|
2017
Q1 | $33.1M | Sell |
1,020,489
-33,274
| -3% | -$1.05M | 1.32% | 12 |
|
|
2016
Q4 | $32.5M | Buy |
1,053,763
+38,574
| +4% | +$1.18M | 1.34% | 12 |
|
|
2016
Q3 | $32.6M | Buy |
1,015,189
+24,364
| +2% | +$815K | 1.33% | 10 |
|
|
2016
Q2 | $33.1M | Sell |
990,825
-3,401
| -0.3% | -$109K | 1.35% | 10 |
|
|
2016
Q1 | $28M | Buy |
994,226
+16,340
| +2% | +$467K | 1.14% | 18 |
|
|
2015
Q4 | $29.9M | Sell |
977,886
-153,881
| -14% | -$4.84M | 1.18% | 16 |
|
|
2015
Q3 | $33.7M | Sell |
1,131,767
-144,771
| -11% | -$4.64M | 1.31% | 11 |
|
|
2015
Q2 | $40.6M | Sell |
1,276,538
-50,316
| -4% | -$1.64M | 1.34% | 7 |
|
|
2015
Q1 | $43.8M | Buy |
1,326,854
+825
| +0.1% | +$26.2K | 1.41% | 7 |
|
|
2014
Q4 | $39.2M | Buy |
+1,326,029
| New | +$38M | 1.27% | 13 |
|
Other funds holding PFE
SVB Wealth's PFE Position: Q2 2026 in Review
SVB Wealth reduced its Pfizer (PFE) stake by 0.42% in Q2 2026, selling an estimated $10.4K and leaving 93,921 shares worth $2.26M. The position accounts for 0.14% of the portfolio, ranked #133.
SVB Wealth first reported a position in PFE in Q4 2014 and has held it in 45 quarters since. The position peaked at $43.8M in Q1 2015. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SVB Wealth held 93,921 shares of Pfizer worth $2.26M as of Q2 2026.
- SVB Wealth sold 398 Pfizer shares in Q2 2026, an estimated $10.4K.
- Pfizer made up 0.14% of SVB Wealth's portfolio in Q2 2026, its #133 holding.
- SVB Wealth first reported a position in Pfizer in Q4 2014 and has held it in 45 quarters since.
- SVB Wealth's Pfizer position peaked at $43.8M in Q1 2015.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SVB Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.